Jeffrey M. Isner
Impact in
- Genetics top 0.05%
- Mesenchymal stem cell research
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Cardiac Valve Diseases and Treatments 38
- Surgery 134
- Coronary Interventions and Diagnostics 79
- Peripheral Artery Disease Management 34
- Cardiac Structural Anomalies and Repair 20
- Co-authors
- Takayuki Asahara (46 shared papers)Marcy Silver (30 shared papers)Marianne Kearney (63 shared papers)Douglas W. Losordo (68 shared papers)Toyoaki Murohara (12 shared papers)Bernhard Witzenbichler (11 shared papers)Haruchika Masuda (11 shared papers)Alison B. Sullivan (7 shared papers)
- Journals
- Circulation (63 papers)Journal of the American College of Cardiology (52 papers)The American Journal of Cardiology (48 papers)American Heart Journal (20 papers)Journal of Clinical Investigation (16 papers)
- Partner nations
- United StatesPakistanJapan
In The Last Decade
Jeffrey M. Isner
377 papers receiving 53.2k citations
Jeffrey M. Isner's Hit Papers
Peers
Comparison fields: 5 of 184
- Genetics 6.0k
- Cancer Research 6.4k
- Molecular Biology 28.7k
- Cardiology and Cardiovascular Medicine 8.2k
- Surgery 14.7k
Countries citing papers authored by Jeffrey M. Isner
This map shows the geographic impact of Jeffrey M. Isner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Isner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Isner more than expected).
Fields of papers citing papers by Jeffrey M. Isner
This network shows the impact of papers produced by Jeffrey M. Isner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Isner. The network helps show where Jeffrey M. Isner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey M. Isner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 386 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Isolation of Putative Progenitor Endothelial Cells for Angiogenesis Hit paper breakdown → | 1997 | 7338 |
| 2 | Bone Marrow Origin of Endothelial Progenitor Cells Responsible for Postnatal Vasculogenesis in Physiological and Pathological Neovascularization Hit paper breakdown → | 1999 | 2747 |
| 3 | Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization Hit paper breakdown → | 2000 | 1610 |
| 4 | VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells Hit paper breakdown → | 1999 | 1580 |
| 5 | Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. Hit paper breakdown → | 1998 | 1073 |
| 6 | Therapeutic Potential of Ex Vivo Expanded Endothelial Progenitor Cells for Myocardial Ischemia Hit paper breakdown → | 2001 | 1018 |
| 7 | Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization Hit paper breakdown → | 2003 | 1008 |
| 8 | Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia Hit paper breakdown → | 1998 | 920 |
| 9 | Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. Hit paper breakdown → | 1994 | 911 |
| 10 | Gene Therapy for Myocardial Angiogenesis Hit paper breakdown → | 1998 | 823 |
| 11 | Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb Hit paper breakdown → | 1996 | 816 |
| 12 | Statin Therapy Accelerates Reendothelialization Hit paper breakdown → | 2002 | 803 |
| 13 | 1999 | 663 | |
| 14 | 1999 | 651 | |
| 15 | Mouse model of angiogenesis. | 1998 | 625 |
| 16 | Apoptosis in Human Atherosclerosis and Restenosis Hit paper breakdown → | 1995 | 603 |
| 17 | Tie2 Receptor Ligands, Angiopoietin-1 and Angiopoietin-2, Modulate VEGF-Induced Postnatal Neovascularization Hit paper breakdown → | 1998 | 600 |
| 18 | 2001 | 571 | |
| 19 | 2003 | 555 | |
| 20 | 2001 | 542 |
About Jeffrey M. Isner
Jeffrey M. Isner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 386 papers that have together received 56.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (102 papers), Coronary Interventions and Diagnostics (79 papers), Cardiac Valve Diseases and Treatments (38 papers), Cardiac Imaging and Diagnostics (38 papers), Peripheral Artery Disease Management (34 papers), Cardiac Structural Anomalies and Repair (20 papers), Cerebrovascular and Carotid Artery Diseases (19 papers) and Infective Endocarditis Diagnosis and Management (17 papers). The work is most often cited by research in Genetics (6.0k citations), Cancer Research (6.4k citations), Molecular Biology (28.7k citations), Cardiology and Cardiovascular Medicine (8.2k citations) and Surgery (14.7k citations). Jeffrey M. Isner has collaborated with scholars based in United States, Pakistan and Japan. Frequent co-authors include Takayuki Asahara, Marcy Silver, Marianne Kearney, Douglas W. Losordo, Toyoaki Murohara, Bernhard Witzenbichler, Haruchika Masuda, Alison B. Sullivan, Christoph Kalka and Rien van der Zee. Their work appears in journals such as Circulation, Journal of the American College of Cardiology, The American Journal of Cardiology, American Heart Journal and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.